Pulse Wave Velocity as a Biomarker of Ageing

Pulse wave velocity is a physiological biomarker used to quantify arterial stiffness. It is calculated from the distance between two arterial recording sites and the time it takes the pressure wave generated by the heartbeat to travel between them. Because stiffer arteries transmit pressure waves faster, pulse wave velocity is widely used in research on vascular ageing and cardiovascular risk. [1] [2] [8]

Who This Is Useful For

This page is useful for readers who want to understand what pulse wave velocity adds beyond a standard blood pressure reading. It is especially relevant for interpreting vascular age claims, arterial stiffness studies, cardiovascular-risk research, and biomarker panels that include physiological measures rather than only molecular clocks. [1] [6] [12]

What Pulse Wave Velocity Measures

When the heart ejects blood, a pressure wave moves through the arterial tree. Pulse wave velocity describes the speed of that wave across a defined arterial segment. The measure is functional rather than molecular: it captures the mechanical behavior of an arterial pathway under the conditions of measurement. [1] [2]

The most established research form is carotid-femoral pulse wave velocity, which approximates stiffness along the central aortic pathway. Other forms, including brachial-ankle and device-estimated measures, can be useful in large cohorts, but they do not always capture the same arterial segment or the same degree of central aortic specificity. [1] [2] [5]

Measurement Types at a Glance

Why It Changes With Age

Ageing is associated with structural and functional changes in large arteries, including altered elastin and collagen contribution, endothelial dysfunction, calcification, inflammation, oxidative stress, and changes in vascular smooth muscle behavior. These processes reduce arterial compliance and increase the speed of pressure-wave transmission. [3] [4] [11]

Pulse wave velocity is therefore an integrated vascular phenotype. It does not isolate one molecular pathway, and a higher value can reflect ageing-related remodeling together with hypertension, diabetes, kidney disease, atherosclerosis, medication context, or acute haemodynamic state. [4] [5] [11]

Reference Values and Vascular Age

Reference-value studies show that pulse wave velocity rises across adulthood and is strongly shaped by blood pressure. The Reference Values for Arterial Stiffness Collaboration combined data across populations to define age and blood-pressure categories, while the LIFE-Adult study reported age-dependent percentiles for multiple pulse wave velocity pathways. [5] [6]

Vascular age estimates usually compare a person's value with a reference distribution. That comparison can be informative, but it is not a direct measurement of biological age in every tissue. Reviews of pulse-wave modelling emphasize that vascular age depends on the signal, model, device, arterial pathway, and reference population used to translate the measurement. [6] [12]

Evidence From Outcome Studies

Pulse wave velocity has prognostic evidence beyond its role as a descriptive stiffness measure. A systematic review and meta-analysis found that higher aortic pulse wave velocity was associated with future cardiovascular events and all-cause mortality. [7]

An individual participant meta-analysis reported that aortic pulse wave velocity improved cardiovascular event prediction in models that already included conventional risk factors. Updated meta-analyses and mortality-focused reviews also support a population-level association between higher carotid-femoral or aortic pulse wave velocity and worse outcomes. [8] [9] [10]

Measurement and Protocol Issues

Pulse wave velocity is sensitive to protocol. Consensus statements emphasize standardizing participant preparation, body position, measurement pathway, travel-distance calculation, waveform detection, device type, blood pressure reporting, and repeated measurements. [1] [2]

Blood pressure is especially important because higher distending pressure can increase measured stiffness even before long-term structural change is considered. This is why pulse wave velocity should not be interpreted as a pure ageing signal without information about current blood pressure and measurement context. [3] [5] [6]

Use as a Biomarker of Ageing

Pulse wave velocity has several features that make it useful in ageing research: it is non-invasive, mechanistically linked to vascular ageing, age-associated in reference cohorts, and connected to cardiovascular outcomes in prospective studies. These features make it a strong biomarker of vascular ageing rather than a broad biological-age clock. [1] [6] [8]

Its strongest interpretation is domain-specific. Pulse wave velocity tells us about arterial stiffness along a measured or estimated pathway, not immune ageing, brain ageing, muscle reserve, kidney function, or total organismal ageing. [2] [11] [12]

Limitations

The main limitation is context dependence. Age, blood pressure, sex, heart rate, body size, disease burden, medication use, measurement device, and calculation method can all influence pulse wave velocity values. This makes single-person interpretation more difficult than group-level analysis. [1] [2] [5]

A second limitation is specificity. A high value may be compatible with accelerated vascular ageing, but it can also reflect hypertension or other cardiometabolic and renal conditions. Pulse wave velocity is therefore best interpreted as a structured vascular signal, not as a diagnostic label for ageing rate. [4] [11]

Evidence Quality and Interpretation

Confidence is strong that pulse wave velocity measures arterial stiffness and that carotid-femoral pulse wave velocity is an established central arterial stiffness method. This is supported by European consensus guidance, an American Heart Association scientific statement, and standardized reference-value work. [1] [2] [6]

Confidence is also strong that higher pulse wave velocity is associated with cardiovascular outcomes at the population level. Confidence is weaker when converting a single value into an exact vascular-age number, because the translation depends on model calibration, reference population, and measurement pathway. [7] [8] [12]

What This Does Not Mean

• It does not mean pulse wave velocity is a complete measure of whole-body biological age. [11] [12]
• It does not mean carotid-femoral, brachial-ankle, and estimated pulse wave velocity are interchangeable. [1] [2] [5]
• It does not mean a higher value proves one specific ageing mechanism is responsible. [4] [11]
• It does not mean vascular age estimates are independent of the reference population and device model used. [6] [12]

Practical Interpretation Examples

• If carotid-femoral PWV is high for age: that pattern is consistent with greater central arterial stiffness, but blood pressure and protocol still need to be considered. [1] [6]
• If a wearable or consumer device reports vascular age: the output is an interpreted estimate, not the same thing as a directly measured biological age for the whole body. [12]
• If two studies report different PWV thresholds: differences may reflect pathway, distance calculation, population risk, and outcome definition rather than a contradiction in the underlying biology. [1] [13]

Related Reading

• Arterial Stiffness and Vascular Ageing
• Blood Pressure Patterns and Vascular Ageing
• Reference Ranges vs Risk Thresholds in Ageing Biomarkers
• Cardiovascular Ageing

Summary

Pulse wave velocity is a well-established biomarker of vascular ageing because it captures arterial stiffness, rises with age and blood pressure, and predicts cardiovascular outcomes in cohort research. Its best use is as a domain-specific vascular measure interpreted with protocol, pressure state, device, and population context, not as a standalone biological-age score. [1] [6] [8] [12]

References

1. Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., et al. (2006). Expert consensus document on arterial stiffness: methodological issues and clinical applications. European Heart Journal. https://pubmed.ncbi.nlm.nih.gov/17000623/
2. Townsend, R. R., Wilkinson, I. B., Schiffrin, E. L., Avolio, A. P., Chirinos, J. A., Cockcroft, J. R., et al. (2015). Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. https://pubmed.ncbi.nlm.nih.gov/26160955/
3. Mitchell, G. F., Parise, H., Benjamin, E. J., Larson, M. G., Keyes, M. J., Vita, J. A., Vasan, R. S., & Levy, D. (2004). Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension. https://pubmed.ncbi.nlm.nih.gov/15123572/
4. O'Rourke, M. F., & Hashimoto, J. (2007). Mechanical factors in arterial aging: a clinical perspective. Journal of the American College of Cardiology. https://pubmed.ncbi.nlm.nih.gov/17692727/
5. Baier, D., Teren, A., Wirkner, K., Loeffler, M., & Scholz, M. (2018). Parameters of pulse wave velocity: determinants and reference values assessed in the population-based study LIFE-Adult. Clinical Research in Cardiology. https://pmc.ncbi.nlm.nih.gov/articles/PMC6208658/
6. Reference Values for Arterial Stiffness' Collaboration. (2010). Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: establishing normal and reference values. European Heart Journal. https://pmc.ncbi.nlm.nih.gov/articles/PMC2948201/
7. Vlachopoulos, C., Aznaouridis, K., & Stefanadis, C. (2010). Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. Journal of the American College of Cardiology. https://pubmed.ncbi.nlm.nih.gov/20338492/
8. Ben-Shlomo, Y., Spears, M., Boustred, C., May, M., Anderson, S. G., Benjamin, E. J., et al. (2014). Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. Journal of the American College of Cardiology. https://pubmed.ncbi.nlm.nih.gov/24239664/
9. Zhong, Q., Hu, M. J., Cui, Y. J., Liang, L., Zhou, M. M., Yang, Y. W., & Huang, F. (2018). Carotid-femoral pulse wave velocity in the prediction of cardiovascular events and mortality: an updated systematic review and meta-analysis. Angiology. https://pubmed.ncbi.nlm.nih.gov/29172654/
10. Sequi-Dominguez, I., Cavero-Redondo, I., Alvarez-Bueno, C., Pozuelo-Carrascosa, D. P., Nunez de Arenas-Arroyo, S., & Martinez-Vizcaino, V. (2020). Accuracy of pulse wave velocity predicting cardiovascular and all-cause mortality. A systematic review and meta-analysis. Journal of Clinical Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC7408852/
11. Nilsson, P. M., Boutouyrie, P., & Laurent, S. (2009). Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension. https://pubmed.ncbi.nlm.nih.gov/19652083/
12. Charlton, P. H., Mariscal Harana, J., Vennin, S., Li, Y., Chowienczyk, P., & Alastruey, J. (2023). Arterial pulse wave modeling and analysis for vascular-age studies: a review from VascAgeNet. American Journal of Physiology-Heart and Circulatory Physiology. https://pubmed.ncbi.nlm.nih.gov/37000606/
13. An, D. W., Hansen, T. W., Aparicio, L. S., Chori, B., Huang, Q. F., Wei, F. F., et al. (2023). Derivation of an outcome-driven threshold for aortic pulse wave velocity: an individual-participant meta-analysis. Hypertension. https://pmc.ncbi.nlm.nih.gov/articles/PMC10424824/